A detailed history of First Trust Advisors LP transactions in Illumina, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 666,110 shares of ILMN stock, worth $95.2 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
666,110
Previous 587,027 13.47%
Holding current value
$95.2 Million
Previous $61.3 Million 41.76%
% of portfolio
0.09%
Previous 0.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$105.28 - $135.9 $8.33 Million - $10.7 Million
79,083 Added 13.47%
666,110 $86.9 Million
Q2 2024

Aug 13, 2024

BUY
$101.05 - $133.57 $4.73 Million - $6.25 Million
46,781 Added 8.66%
587,027 $61.3 Million
Q1 2024

May 13, 2024

SELL
$127.73 - $147.2 $7.6 Million - $8.76 Million
-59,535 Reduced 9.93%
540,246 $74.2 Million
Q4 2023

Feb 13, 2024

BUY
$92.79 - $142.53 $14.5 Million - $22.3 Million
156,297 Added 35.24%
599,781 $83.5 Million
Q3 2023

Nov 13, 2023

BUY
$128.91 - $192.44 $8.84 Million - $13.2 Million
68,586 Added 18.29%
443,484 $60.9 Million
Q2 2023

Aug 14, 2023

SELL
$183.43 - $232.67 $6.37 Million - $8.08 Million
-34,722 Reduced 8.48%
374,898 $70.3 Million
Q1 2023

May 15, 2023

BUY
$193.75 - $232.55 $24.6 Million - $29.6 Million
127,100 Added 44.99%
409,620 $95.3 Million
Q4 2022

Feb 09, 2023

SELL
$187.24 - $242.74 $14.5 Million - $18.8 Million
-77,644 Reduced 21.56%
282,520 $57.1 Million
Q3 2022

Nov 14, 2022

BUY
$177.23 - $227.44 $21.7 Million - $27.8 Million
122,362 Added 51.46%
360,164 $68.7 Million
Q2 2022

Aug 12, 2022

BUY
$181.58 - $368.0 $9.24 Million - $18.7 Million
50,913 Added 27.24%
237,802 $43.8 Million
Q1 2022

May 13, 2022

SELL
$303.87 - $423.8 $4.69 Million - $6.54 Million
-15,438 Reduced 7.63%
186,889 $65.3 Million
Q4 2021

Feb 08, 2022

SELL
$347.28 - $421.83 $1.41 Million - $1.72 Million
-4,071 Reduced 1.97%
202,327 $77 Million
Q3 2021

Nov 15, 2021

SELL
$405.61 - $524.84 $156,971 - $203,113
-387 Reduced 0.19%
206,398 $83.7 Million
Q2 2021

Aug 16, 2021

SELL
$372.84 - $481.5 $11.5 Million - $14.8 Million
-30,827 Reduced 12.97%
206,785 $97.9 Million
Q1 2021

May 14, 2021

SELL
$361.28 - $504.76 $5.9 Million - $8.24 Million
-16,325 Reduced 6.43%
237,612 $91.3 Million
Q4 2020

Feb 02, 2021

SELL
$292.7 - $370.96 $98.3 Million - $125 Million
-335,780 Reduced 56.94%
253,937 $94 Million
Q3 2020

Nov 05, 2020

BUY
$268.51 - $400.74 $88 Million - $131 Million
327,887 Added 125.23%
589,717 $182 Million
Q2 2020

Jul 22, 2020

BUY
$256.46 - $373.01 $13.2 Million - $19.2 Million
51,437 Added 24.45%
261,830 $97 Million
Q1 2020

May 06, 2020

BUY
$209.2 - $335.53 $1.37 Million - $2.2 Million
6,562 Added 3.22%
210,393 $57.5 Million
Q4 2019

Feb 03, 2020

SELL
$288.29 - $335.49 $36.7 Million - $42.7 Million
-127,291 Reduced 38.44%
203,831 $67.6 Million
Q3 2019

Nov 04, 2019

SELL
$266.84 - $378.23 $3.42 Million - $4.84 Million
-12,801 Reduced 3.72%
331,122 $101 Million
Q2 2019

Jul 30, 2019

SELL
$300.59 - $368.15 $39.6 Million - $48.5 Million
-131,783 Reduced 27.7%
343,923 $127 Million
Q1 2019

May 09, 2019

SELL
$272.57 - $321.18 $8.91 Million - $10.5 Million
-32,687 Reduced 6.43%
475,706 $148 Million
Q4 2018

Feb 07, 2019

BUY
$272.46 - $366.54 $9.18 Million - $12.4 Million
33,707 Added 7.1%
508,393 $152 Million
Q3 2018

Oct 25, 2018

BUY
$279.04 - $367.06 $39.2 Million - $51.5 Million
140,364 Added 41.98%
474,686 $174 Million
Q2 2018

Aug 02, 2018

SELL
$228.17 - $292.07 $2.65 Million - $3.4 Million
-11,627 Reduced 3.36%
334,322 $93.4 Million
Q1 2018

Apr 23, 2018

BUY
$209.54 - $253.91 $10.5 Million - $12.7 Million
49,978 Added 16.89%
345,949 $81.8 Million
Q4 2017

Feb 08, 2018

SELL
$202.23 - $230.03 $915,495 - $1.04 Million
-4,527 Reduced 1.51%
295,971 $64.7 Million
Q3 2017

Oct 24, 2017

BUY
$172.3 - $213.93 $51.8 Million - $64.3 Million
300,498
300,498 $59.9 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.